Description
- For the prevention and treatment of deep vein thrombosis (DVT) and prevent pulmonary embolism.
- A trusted anticoagulant
Indications
- Oxarin is indicated for the prophylaxis of deep vein thrombosis (DVT) which can lead to pulmonary embolism:
• To prevent the formation of deep vein thrombosis (blood clots), which can occur as a complication during orthopedic surgery such as hip or knee surgery or an intra-abdominal procedure (in the body cavity beneath the diaphragm containing the stomach, intestines, liver and other organs);
• Prevent the formation of deep vein thrombosis in hospitalized patients at risk of thromboembolic complications (obstruction of a blood vessel by a blood clot) due to severely restricted mobility during acute illnesses (heart failure [reduced capacity of the heart to pump blood], respiratory) failure or serious chest infections);
• Treat deep vein thrombosis with or without pulmonary embolism (blockage of blood vessels in the lungs). - Prophylaxis of ischemic complications of unstable angina and non-Q wave myocardial infarction
OXARIN is indicated for the prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction, when administered concomitantly with aspirin. - Treatment of acute ST-segment elevation myocardial infarction
Administered concurrently with aspirin, OXARIN has been shown to reduce the combined effect rate of recurrent myocardial infarction or death in patients with acute ST-segment elevation myocardial infarction (STEMI). ). - Prevention of thrombus formation during hemodialysis
• Deep vein thrombosis prophylaxis, abdominal surgery
• Deep vein thrombosis prophylaxis, knee arthroplasty
• Deep vein thrombosis prophylaxis, hip arthroplasty
• Prophylaxis of deep vein thrombosis in medical patients
• Acute deep vein thrombosis without pulmonary embolism, hospital treatment
• Unstable angina and non-Q wave myocardial infarction
• Acute myocardial infarction with ST segment elevation in patients younger than 75 years
• Acute myocardial infarction with ST segment elevation in patients aged ≥ 75 years - Reduce the dose in patients with severe renal impairment
• Prophylaxis in abdominal surgery
• Prophylaxis in hip replacement or knee surgery
• Prophylaxis in hospitalized patients with an acute illness
• Hospital treatment of acute deep vein thrombosis with or without pulmonary embolism, when administered in combination with warfarin sodium.
• Pulmonary embolism treatment
• Outpatient treatment of acute deep vein thrombosis without pulmonary embolism, when administered in combination with warfarin sodium
• Prophylaxis of ischemic complications of unstable angina and non-Q wave myocardial infarction, when administered simultaneously with aspirin
• Treatment of acute myocardial infarction with ST-segment elevation in patients aged less than 75 years, in combination with aspirin
• Treatment of acute ST-segment elevation myocardial infarction in patients over 75 years of age in combination with aspirin
• Prevention of coagulation in the extracorporeal circuit during hemodialysis